The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Bugger. SOOOOOOOOOOO close.
Following the rather undeserved drop on predictable financial news, I'm now looking at 42-44p as the area to buy.
Below 54p to buy now. Tempting.
More like a steal!
Just the 30% down since this forecast.
Looks a buy at 54p IMO.
Looks like a lot of PIs been sitting on sidelines, could have strong run back to 80s now imho
A nice 33% rise would be a good Indicator .
Best of All
Hopefully with us soon.
Best of All
SP drifted away again. Low volume/ interest without any news.
C'mon board ...drop a biggie
Loaded up here ...I think news is round the corner.
Quiet board but when news drops and this flys, the herd will definitely arrive.
Strong strong potential here with a relative low mcap
Big things coming when they line you up next to Medronic.
https://thefairreporter.com/bioprosthetics-market-2023-analysis-by-product-types-applications-industry-top-players-regions-market-overview/
https://www.sharesmagazine.co.uk/news/market/6010470/Broker-Forecast-Stockdale-Securities-issues-a-broker-note-on-AorTech-International-PLC
Conservative 400p....
I'm also of the opinion that some news could be close.
The size of the global majors in this field is truly immense.
They will think nothing of buying a genuine game-changing technology if it's proven and validated by the sort of experts (who've consulted to those very same global majors as well as the US FDA)
If AorTech AOR succeed with their Heart Valve project the sky is the limit
£100 per share is the all-time high (i.e. would be a £1.4bn market cap)
For anyone who thinks that is 'absurd'
MDT Medtronic Mkt Cap $115bn
ABT Abbot Labs (St Judes Medical) Mkt Cap $106bn
BSX Boston Scientific Mkt Cap $41bn
EW Edwards Lifesciences Mkt Cap $29bn
That's what I thought! Did he buy or sell? Holding seems to have increased but % voting rights decreased??
16th July threshold crossed and they publish it now!?
very odd changed back now
Why is this showing as Henry Boot and not Aortech
Definitely and further imho wouldn’t want to be out of these over the weekend
Back to 100p now it looks
Rising nicely on the back of yesterday's fantastic news.
More to come here yet...
Fantastic news on all fronts
...this needs to be priced at at least year highs, around the £1 mark
Excellent progress and "We are also delighted to have been informed that the US Patent and Trademark Office will issue US Patent Number 10,059,807 on a new AorTech patent entitled GELS further building on our family of biostable materials"
Thanks for your informative reply.I was thinking along the same lines myself
I’m not sure it implies a 12 month target. It’s a target based on potential progress. What they have said is if good progress is made, their 400p target is likely to be conservative. I am not hanging anything on a time target. That’s not the point of it. It’s all down to what the company does. The broker has said it will update its outlook after the interims in December so I expect it will be advised by the company of the state of play of the projects at that time.
Thanks IntraVnus.I read that too.Can we assume definitely that excerpt from the note implies a 12 month price target?